Skip to main content
logo
NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia flag Australia · Delayed Price · Currency is AUD
0.0660
+0.0010 (1.54%)
Jul 15, 2026, 10:43 AM AEST

ASX:NSB Revenue

NeuroScientific Biopharmaceuticals had revenue of 317.91K AUD in the half year ending December 31, 2025. This brings the company's revenue in the last twelve months to 317.91K, down -85.63% year-over-year.

Revenue (ttm)
317.91K
Revenue Growth
-85.63%
P/S Ratio
68.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
21.62M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 2025---
Jun 30, 20242.21M-2.74M-55.34%
Jun 30, 20234.95M--
Jun 30, 2022---
Jun 30, 2021958.77K--
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
EZZ Life Science Holdings61.40M
Immuron7.48M
Neurotech International7.07M
Noxopharm3.40M
Proteomics International Laboratories3.21M
Argenica Therapeutics1.01M
Cambium Bio668.79K
AdAlta608.07K
Revenue Rankings

NeuroScientific Biopharmaceuticals News

More News